This work is licensed under the Creative Commons Attribution 4.0 International License.
Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011; 140:124–31.WilliamsCDStengelJAsikeMITorresDMShawJContrerasMPrevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study20111401243110.1053/j.gastro.2010.09.03820858492Search in Google Scholar
Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology. 2010; 51:1979–87.SpeliotesEKMassaroJMHoffmannUVasanRSMeigsJBSahaniDVFatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study20105119798710.1002/hep.23593302316020336705Search in Google Scholar
Bae JC, Cho YK, Lee WY, Seo HI, Rhee EJ, Park SE, et al. Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects. Am J Gastroenterol. 2010; 105:2389–95.BaeJCChoYKLeeWYSeoHIRheeEJParkSEImpact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects201010523899510.1038/ajg.2010.27520628364Search in Google Scholar
Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, et al. Prevalence and risk factors of non alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol. 2006; 21:138–43.ParkSHJeonWKKimSHKimHJParkDIChoYKPrevalence and risk factors of non alcoholic fatty liver disease among Korean adults2006211384310.1111/j.1440-1746.2005.04086.x16706825Search in Google Scholar
Sirota JC, McFann K, Targher G, Johnson RJ, Chonchol M, Jalal DI. Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the National Health and Nutrition Examination Survey. Metabolism. 2013; 62:392–9.SirotaJCMcFannKTargherGJohnsonRJChoncholMJalalDIElevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the National Health and Nutrition Examination Survey201362392910.1016/j.metabol.2012.08.013356504723036645Search in Google Scholar
Lu Z-Y, Shao Z, Li Y-L, Wulasihan M, Chen X-H. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: an 8-year follow-up study. World J Gastroenterol. 2016; 22:3663–9.LuZ-YShaoZLiY-LWulasihanMChenX-HPrevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: an 8-year follow-up study2016223663910.3748/wjg.v22.i13.3663481465227053858Search in Google Scholar
Feig DI, Kang D-H, Johnson RJ. Uric acid and cardiovascular risk. N Eng J Med. 2008; 359:1811–21.FeigDIKangD-HJohnsonRJUric acid and cardiovascular risk200835918112110.1056/NEJMra0800885268433018946066Search in Google Scholar
Lee JW, Cho YK, Ryan M, Kim H, Lee SW, Chang E, et al. Serum uric acid as a predictor for the development of nonalcoholic fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut Liver. 2010; 4:378–83.LeeJWChoYKRyanMKimHLeeSWChangESerum uric acid as a predictor for the development of nonalcoholic fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study201043788310.5009/gnl.2010.4.3.378295635220981217Search in Google Scholar
Ryu S, Chang Y, Zhang Y, Kim S-G, Cho J, Son HJ, et al. A cohort study of hyperuricemia in middle-aged South Korean men. Am J Epidemiol. 2012; 175:133–43.RyuSChangYZhangYKimS-GChoJSonHJA cohort study of hyperuricemia in middle-aged South Korean men20121751334310.1093/aje/kwr29122156041Search in Google Scholar
Petta S, Camma C, Cabibi D, Di Marco V, Craxì A. Hyperuricemia is associated with histological liver damage in patients with non alcoholic fatty liver disease. Aliment Pharmacol Ther. 2011; 34:757–66.PettaSCammaCCabibiDDi MarcoVCraxìAHyperuricemia is associated with histological liver damage in patients with non alcoholic fatty liver disease2011347576610.1111/j.1365-2036.2011.04788.x21790685Search in Google Scholar
Ballestri S, Nascimbeni F, Romagnoli D, Lonardo A. The independent predictors of non-alcoholic steatohepatitis and its individual histological features. Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment. Hepatol Res. 2016; 46:1074–87.BallestriSNascimbeniFRomagnoliDLonardoAThe independent predictors of non-alcoholic steatohepatitis and its individual histological features. Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment20164610748710.1111/hepr.1265626785389Search in Google Scholar
Sandra S, Lesmana CRA, Purnamasari D, Kurniawan J, Gani RA. Hyperuricemia as an independent risk factor for non-alcoholic fatty liver disease (NAFLD) progression evaluated using controlled attenuation parameter-transient elastography: lesson learnt from tertiary referral center. Diabetes Metab Syndr. 2019; 13:424–8.SandraSLesmanaCRAPurnamasariDKurniawanJGaniRAHyperuricemia as an independent risk factor for non-alcoholic fatty liver disease (NAFLD) progression evaluated using controlled attenuation parameter-transient elastography: lesson learnt from tertiary referral center201913424810.1016/j.dsx.2018.10.00130641737Search in Google Scholar
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ. 2007; 85:867–72.von ElmEAltmanDGEggerMPocockSJGøtzschePCVandenbrouckeJPSTROBE InitiativeThe Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies2007858677210.1097/EDE.0b013e318157765418049194Search in Google Scholar
Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006; 6:33. doi: 10.1186/1471-230X-6-33BedogniGBellentaniSMiglioliLMasuttiFPassalacquaMCastiglioneATiribelliCThe Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population200663310.1186/1471-230X-6-33163665117081293Open DOISearch in Google Scholar
Hagström H, Nasr P, Ekstedt M, Stål P, Hultcrantz R, Kechagias S. Accuracy of noninvasive scoring systems in assessing risk of death and liver-related endpoints in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2019; 17:1148–56.e4. doi: 10.1016/j.cgh.2018.11.030HagströmHNasrPEkstedtMStålPHultcrantzRKechagiasSAccuracy of noninvasive scoring systems in assessing risk of death and liver-related endpoints in patients with nonalcoholic fatty liver disease201917114856.e410.1016/j.cgh.2018.11.03030471458Open DOISearch in Google Scholar
McPherson S, Hardy T, Dufour J-F, Petta S, Romero-Gomez M, Allison M, et al. Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis. Am J Gastroenterol. 2017; 112:740–51.McPhersonSHardyTDufourJ-FPettaSRomero-GomezMAllisonMAge as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis20171127405110.1038/ajg.2016.453541856027725647Search in Google Scholar
Grant EG. Liver. In: Mittelstaedt CA, editor. General ultrasound. New York: Churchill Livingstone; 1992, pp. 173–248.GrantEGLiverIn:MittelstaedtCAeditor.New YorkChurchill Livingstone1992173248Search in Google Scholar
Li C, Hsieh M-C, Chang S-J. Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol. 2013; 25:210–6.LiCHsiehM-CChangS-JMetabolic syndrome, diabetes, and hyperuricemia201325210610.1097/BOR.0b013e32835d951e23370374Search in Google Scholar
Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018; 67:328–57.ChalasaniNYounossiZLavineJECharltonMCusiKRinellaMThe diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases2018673285710.1002/hep.2936728714183Search in Google Scholar
Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2013; 19:325–48.Korean Association for the Study of the Liver (KASL)KASL clinical practice guidelines: management of nonalcoholic fatty liver disease2013193254810.3350/cmh.2013.19.4.325389443224459637Search in Google Scholar
Fernández Rodríguez CM, Aller R, Gutiérrez García ML, Ampuero J, Gómez-Camarero J, Martín-Mateos RM, et al. Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD). Rev Esp Enferm Dig. 2019; 111:264–9. [in English]Fernández RodríguezCMAllerRGutiérrez GarcíaMLAmpueroJGómez-CamareroJMartín-MateosRMHigher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD)20191112649[in English]10.17235/reed.2019.5965/201830810330Search in Google Scholar
Jaruvongvanich V, Ahuja W, Wirunsawanya K, Wijarnpreecha K, Ungprasert P. Hyperuricemia is associated with nonalcoholic fatty liver disease activity score in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2017; 29:1031–5.JaruvongvanichVAhujaWWirunsawanyaKWijarnpreechaKUngprasertPHyperuricemia is associated with nonalcoholic fatty liver disease activity score in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis2017291031510.1097/MEG.000000000000093128639970Search in Google Scholar
Jaruvongvanich V, Ahuja W, Wijarnpreecha K, Ungprasert P. Hyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2017; 29:694–7.JaruvongvanichVAhujaWWijarnpreechaKUngprasertPHyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis201729694710.1097/MEG.000000000000086528252464Search in Google Scholar
Yoneda M, Thomas E, Sumida Y, Imajo K, Hyogo H, Fujii H, et al. Uric acid levels decrease with fibrosis progression in patients with nonalcoholic fatty liver disease. Clin Biochem. 2014; 47:1138–9.YonedaMThomasESumidaYImajoKHyogoHFujiiHUric acid levels decrease with fibrosis progression in patients with nonalcoholic fatty liver disease2014471138910.1016/j.clinbiochem.2014.04.02624797484Search in Google Scholar
Sertoglu E, Ercin CN, Celebi G, Gurel H, Kayadibi H, Genc H, et al. The relationship of serum uric acid with non-alcoholic fatty liver disease. Clin Biochem. 2014; 47:383–8.SertogluEErcinCNCelebiGGurelHKayadibiHGencHThe relationship of serum uric acid with non-alcoholic fatty liver disease201447383810.1016/j.clinbiochem.2014.01.02924525254Search in Google Scholar
Ayonrinde OT, Olynyk JK, Beilin LJ, Mori TA, Pennell CE, de Klerk N, et al. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Hepatology. 2011; 53:800–9.AyonrindeOTOlynykJKBeilinLJMoriTAPennellCEde KlerkNGender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease201153800910.1002/hep.2409721374659Search in Google Scholar
Lanaspa MA, Sanchez-Lozada LG, Choi YJ, Cicerchi C, Kanbay M, Roncal-Jimenez CA, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem. 2012; 287:40732–44.LanaspaMASanchez-LozadaLGChoiYJCicerchiCKanbayMRoncal-JimenezCAUric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver2012287407324410.1074/jbc.M112.399899350478623035112Search in Google Scholar
Choi Y-J, Shin H-S, Choi HS, Park J-W, Jo I, Oh E-S, et al. Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes. Lab Invest. 2014; 94:1114–25.ChoiY-JShinH-SChoiHSParkJ-WJoIOhE-SUric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes20149411142510.1038/labinvest.2014.9825111690Search in Google Scholar
Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, Le M, et al. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes. 2013; 62:3307–15.JohnsonRJNakagawaTSanchez-LozadaLGShafiuMSundaramSLeMSugar, uric acid, and the etiology of diabetes and obesity20136233071510.2337/db12-1814378148124065788Search in Google Scholar
Vilar-Gomez E, Chalasani N. Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers. J Hepatol. 2018; 68:305–15.Vilar-GomezEChalasaniNNon-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers2018683051510.1016/j.jhep.2017.11.01329154965Search in Google Scholar